EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin G Following Infection and Exposure in a Household Cohort, 2014–2022

Kalee E Rumfelt iD, Casey Juntila, Matthew Smith iD, Amy Callear, Yangyupei Yang iD, Arnold S Monto, Adam S Lauring iD, Emily T Martin

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Kalee E Rumfelt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Michigan, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Immunoglobulin G, Antibodies, Viral, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDC HHS, NCIRD CDC HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little is known about the strength and durability of protection provided by prefusion F (pre-F) immunoglobulin G (IgG) after respiratory syncytial virus (RSV) infection/exposure.

Methods

We analyzed 1019 sera from 422 individuals in 173 households, collected 365 days before and after RSV infection or exposure (2014–2022), from a longitudinal cohort with active respiratory infection surveillance. IgG against RSV pre-F was measured by electrochemiluminescence assay. We used a Cox model, adjusted for age, to assess the association between log4 preinfection/exposure IgG and risk of infection. We compared pre- and postinfection/exposure IgG geometric mean concentration increases among cases and household contacts to identify asymptomatic infections. Generalized additive mixed models predicted IgG concentrations over time.

Results

We identified 113 confirmed RSV cases and 377 exposed household contacts. Cases had significantly lower pre-F IgG before infection (P < .05) and significantly higher levels after infection (P < .05). A 1-unit increase in log4 preinfection IgG decreased the risk of infection by 25% (P < .05). Among 58 cases with pre- to post-RSV geometric mean concentration increases, the mean fold increase was 1.12. Eight individuals without confirmed infections had ≥1.12-fold increases and were classified as probable asymptomatic infections. Cases had the highest IgG concentrations after infection, peaking at 1 month (P < .001).

Conclusions

Pre-F IgG is a reliable correlate of protection for RSV infection risk. We found that RSV pre-F IgG–mediated protection starts to wane 6 months after infection. Therefore, scheduling of RSV vaccination should be evaluated so that individuals with the highest risk of severe disease are protected throughout the RSV season.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsImmunoglobulin GAntibodies, ViralRespiratory Syncytial Virus, HumanHumansFemaleMaleInfantFamily CharacteristicsChild, PreschoolLongitudinal StudiesAdultChildAdolescentYoung AdultMiddle AgedCohort StudiesAged

Stichwörter der Autor:innen

IgGRSVantibodyhouseholdshumoral immunity

Substanzen

Immunoglobulin GAntibodies, Viral

Autor:innen und Institutionen

  • Department of Epidemiology, University of Michigan, Ann Arbor, MI, United States.
  • Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
  • Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States.

ORCID-Profile: Kalee E Rumfelt, Matthew Smith, Yangyupei Yang, Adam S Lauring

Förderung

  • CDC HHS
  • NCIRD CDC HHS
  • NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • Centers for Disease Control and Prevention

Zitieren

APA

Rumfelt, K. E., Juntila, C., Smith, M., Callear, A., Yang, Y., Monto, A. S., Lauring, A. S., & Martin, E. T. (2025). Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin G Following Infection and Exposure in a Household Cohort, 2014–2022. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf168

Vancouver

Rumfelt KE, Juntila C, Smith M, Callear A, Yang Y, Monto AS, et al. Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin G Following Infection and Exposure in a Household Cohort, 2014–2022. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf168

BibTeX
@article{Rumfelt2025,
  author = {Rumfelt, Kalee E and Juntila, Casey and Smith, Matthew and Callear, Amy and Yang, Yangyupei and Monto, Arnold S and Lauring, Adam S and Martin, Emily T},
  title = {Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin G Following Infection and Exposure in a Household Cohort, 2014–2022},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf168}
}
Kostenlos starten →